XML 31 R21.htm IDEA: XBRL DOCUMENT
v3.24.2

Earnings Per Share | 6 Months Ended
--- | ---
Jun. 29, 2024
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share:
|  | Three Months Ended |  | Six Months Ended
(in thousands, except per share amounts) |  | June 29, 2024 |  | July 1, 2023 |  | June 29, 2024 |  | July 1, 2023
Numerator: |  |  |  |  |  |  |  |
Net income as reported |  | $ | 45,466 |  |  | $ | 70,071 |  |  | $ | 93,918 |  |  | $ | 158,816 |
Denominator: |  |  |  |  |  |  |  |
Weighted average shares outstanding |  |  |  |  |  |  |  |
Basic |  | 24,822 |  |  | 24,839 |  |  | 24,867 |  |  | 24,810 |
Effect of dilutive securities |  | 208 |  |  | 256 |  |  | 208 |  |  | 268 |
Diluted |  | 25,030 |  |  | 25,095 |  |  | 25,075 |  |  | 25,078 |
Earnings Per Share: |  |  |  |  |  |  |  |
Basic earnings per share |  | $ | 1.83 |  |  | $ | 2.82 |  |  | $ | 3.78 |  |  | $ | 6.40 |
Diluted earnings per share |  | $ | 1.82 |  |  | $ | 2.79 |  |  | $ | 3.75 |  |  | $ | 6.33 |
Potential shares of common stock relating to stock options and restricted share units are excluded from the earnings per share calculation because their effect would be anti-dilutive were 141,729 and 110,598 for the three months ended June 29, 2024 and July 1, 2023, respectively, and 129,096 and 102,283 for the six months ended June 29, 2024 and July 1, 2023, respectively. Share Repurchase Program The Company’s Board of Directors authorized the repurchase of up to $300.0 million in the aggregate of shares of the Company’s common stock under a program for the period May 1, 2021 to April 30, 2024 ("2021 program"). On April 25, 2024, the Company's Board of Directors authorized a new three year program to repurchase up to $300.0 million in the aggregate of shares of the Company's stock for the period May 1, 2024 to April 30, 2027 ("2024 program") to replace the expired 2021 program. During the three and six months ended June 29, 2024, the Company repurchased 109,031 and 179,311 shares of its common stock totaling $24.7 million and $40.9 million, respectively, of which $38.9 million was pursuant to the 2021 program and $2.0 million was pursuant to the 2024 program. The Company did not repurchase shares of its common stock for the three and six months ended July 1, 2023.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration